The oncogenic role and prognostic value of PXDN in human stomach adenocarcinoma
Abstract Stomach adenocarcinoma (STAD) is known for its high prevalence and poor prognosis, which underscores the need for novel therapeutic targets. Peroxidasin (PXDN), an enzyme with peroxidase activity, has been linked to cancer development in previous studies. However, its specific role in STAD...
Saved in:
| Main Authors: | Yuan Tian, Shenghui Qiu, Song Yang, Yuanjian Jiang, Hao Hu, Chengcheng Yang, Jinyong Cao, Shaomin Chen, Mingqing Hao, Hongling Li, Jianlin Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-024-13097-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MASP1 in stomach adenocarcinoma: linking diagnosis, prognosis, and tumor immunity
by: Chuyu Xiao, et al.
Published: (2025-06-01) -
Integrative analysis of anoikis-related prognostic signature to evaluate the immune landscape and predict therapeutic response in stomach adenocarcinoma
by: Ziyi Zhou, et al.
Published: (2025-02-01) -
A multi-omics prognostic model of cuproptosis affects the prognosis of stomach adenocarcinoma
by: Yinying Wu, et al.
Published: (2025-06-01) -
Construction of a novel disulfidptosis and cuproptosis-related lncRNA signature for predicting the clinical outcome and immune response in stomach adenocarcinoma
by: Caihao Qu, et al.
Published: (2025-02-01) -
Predicting immune status and gene mutations in stomach adenocarcinoma patients based on inflammatory response-related prognostic features
by: Huanjun Li, et al.
Published: (2025-04-01)